Bnp Paribas Asset Management Holding S.A. Biomarin Pharmaceutical Inc Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.3 Billion
- Q4 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 133,408 shares of BMRN stock, worth $9.53 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
133,408
Previous 154,163
13.46%
Holding current value
$9.53 Million
Previous $10.8 Million
19.08%
% of portfolio
0.02%
Previous 0.03%
Shares
30 transactions
Others Institutions Holding BMRN
# of Institutions
627Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.62 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.38 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.3 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$1.05 Billion0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$928 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $13.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...